Loading clinical trials...
Loading clinical trials...
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of RO4602522 Added to Background Alzheimer's Disease Therapy in Patients With Moderate Severity Alzheimer's Disease
Conditions
Interventions
RO4602522
Placebo
+4 more
Locations
142
United States
Advanced Research Center, Inc.;In-Patient Unit
Anaheim, California, United States
Neurology Center of North Orange County
Fullerton, California, United States
Torrance Clinical Research
Lomita, California, United States
Artemis Institute for Clinical Research, LLC
San Diego, California, United States
Sharp Mesa Vista Hospital
San Diego, California, United States
San Francisco Clinical Research Center
San Francisco, California, United States
Start Date
October 24, 2012
Primary Completion Date
June 12, 2015
Completion Date
June 12, 2015
Last Updated
May 30, 2017
NCT07033494
NCT06159673
NCT07457138
NCT07422857
NCT07214727
NCT06584357
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions